May 8, 2021

Premium Newspaper

The Premium News Provider

The Centers for Disease Control and Prevention is investigating the death of a Michigan woman from a blood clot 11 days after receiving her J&J.


The family of a Michigan woman says she died of “complications after receiving the Johnson & Johnson COVID-19 vaccine”.

WOOD TV reported that Anne Vanguest, 35, a mother of four from Easton Township, got vaccinated in one go on April 8.

After five days, the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) recommended a temporary halt to J&J due to concerns about blood clotting.

VanGeest says she developed a persistent headache within a few days.

She was eventually taken to Mercy Health St. Mary’s Hospital in Grand Rapids, where she passed away on April 19 – 11 days after her vaccination.

VanGeest (pictured) developed a constant headache and was eventually taken to Mercy Health Saint Mary Hospital, where she died on April 19.

Anne Van Geist, 35, (left and right), of Easton Township, Michigan, received the Johnson & Johnson Vaccine on April 8th. She developed a constant headache and was eventually transferred to Mercy Health St. Mary’s Hospital, where she died on April 19.

This comes after a temporary suspension of the J&J vaccine being lifted after fears of blood clots, mostly in women under the age of 50. Pictured: The J&J vaccine at a pop-up clinic in Staten Island, New York

This comes after a temporary suspension of the J&J vaccine being lifted after fears of blood clots, mostly in women under the age of 50. Pictured: The J&J vaccine at a pop-up clinic in Staten Island, New York

VanGeest’s death certificate states that the cause of her death was “painless subarachnoid hemorrhage,” according to WOOD TV.

This means that a blood clot in the vessel ruptures, causing bleeding into the space between the brain and the surrounding membrane

In a statement from the family provided by Lambert, a public relations firm that provides services to the family for free, the family did not say she died as a result of the Johnson & Johnson vaccine, and instead said that her death was the result of health complications after the injection. .

“It is with deep sadness that we share the news of Anne’s death. Anne (Annie), aged 35, was a loving mother, wife, sister and daughter,” the statement reads.

As an active member of the animal rescue community, Annie will be remembered as a fierce advocate, multitasker, and caring friend by her classmates, fellow volunteers and her family.

“We are asking for privacy for her family as they mourn Annie’s death and celebrate her life.”

On April 13, the Centers for Disease Control and Prevention and the Food and Drug Administration recommended that the shot be discontinued after six women had developed rare but serious blood clots out of 7.2 million vaccines.

The number six was subsequently updated to include 15 of the more than eight million people who had been given the J&J vaccine, equivalent to 0.00018 percent.

All of them had cerebral venous thrombosis (CVST) – a rare type of blood clot that prevents the sinus ducts in the brain from draining blood, which can cause bleeding – along with a low platelet count, known as thrombocytopenia.

The suspension was lifted 10 days later, on April 23, after a panel of scientific advisers decided that the benefits of the vaccine outweigh any risks.

At least three women died and seven were still in hospital when the hiatus was lifted.

In an email to the VanGeest family, the CDC confirmed that they had received a report of her death through the agency’s Adverse Event Reporting System (VAERS).

We got a VAERS report on (Anne’s) case. Introduced by her healthcare provider, “ The email is partially read, according to WOOD TV.

However, the CDC has not confirmed to the station whether or not it is investigating Vangist’s death.

The VanGeest family started a GoFundMe page to cover funeral expenses and create scholarships for their children.

As of Monday afternoon, over $ 27.00 has been raised from its $ 50K Goal.